Your email has been successfully added to our mailing list.

×
0 0 0 -0.00636087355996894 -0.00346314227153869 -0.010530779560393 -0.0139939218319317 -0.0140645982048202
Stock impact report

J&J MET antibody nabs accelerated review status for certain lung cancer patients [Seeking Alpha]

Johnson & Johnson (JNJ) 
Last johnson & johnson earnings: 4/14 06:31 am Check Earnings Report
US:NYSE Investor Relations: jnj.com
Company Research Source: Seeking Alpha
Healthcare J&J MET antibody nabs accelerated review status for certain lung cancer patients Mar. 10, 2020 4:14 PM ET | Johnson & Johnson (JNJ) Douglas W. House The FDA designates Phase 1-stage JNJ-6372 is an EGFR-mesenchymal epithelial transition factor (MET) bispecific antibody that targets activating and resistant EGFR and MET mutations and amplifications. NSCLC with EGFR Exon 20 insertion mutations is resistant to EGFR tyrosine kinase inhibitor (TKI) therapy and represents a poor prognosis for patients. The current standard-of-care is conventional cytotoxic chemo. Breakthrough Therapy status provides for more intensive guidance from the FDA on development, the involvement of more senior agency personnel and a rolling review of the marketing application. Click to subscribe to real-time analytics on JNJ Now read: Johnson & Johnson: A Steadily Growing Dividend Compounder, Buy Low On Coronavirus Fears » From other sites Show less Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for JNJ alerts
Opt-in for
JNJ alerts

from News Quantified
Opt-in for
JNJ alerts

from News Quantified